Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double-Blind, Parallel-Group, Randomized Controlled Trial.

J Clin Hypertens (Greenwich) · 2025 · PMC11771783 · PMID 39821945

Europe PMC DOI

hedged sentence

0.0309

closest p · 0.6× alpha

0.0309

boldest claim

The sentences

did not reach statistical significancep = 0.0309actually significant

It was also noted that the changes in several ABPM indicators of the ALI/AML group did not reach statistical significance compared to the AML group (except for changes in the daytime DBP between the two treatment groups, p = 0.0309).

also in 20,614 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.